Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
23
EWTX Quote, Financials, Valuation and Earnings
Last price:
$11.41
Seasonality move
:
7.1%
Day range:
$11.28 - $11.85
52-week range:
$10.60 - $38.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.37x
Volume:
1.3M
Avg. volume:
2.5M
1-year change:
-30.75%
Market cap:
$1.1B
Revenue:
--
EPS (TTM):
-$1.45
Earnings Data
Next earnings date for EWTX
May 09
2025
Most recent earnings per share
-$0.42
Beat by $0.00
(Mar 3/2025)
Consensus Estimate
-$0.42
(Mar 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EWTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.44 | -- |
| 05/09/2025 | Q1 | -- | -- | -- | -$0.42 | -- |
| 03/03/2025 | Q4 | -- | -- | -$0.42 | -$0.42 | $0.00 |
| 11/07/2024 | Q3 | -- | -- | -$0.36 | -$0.37 | $0.01 |
| 08/08/2024 | Q2 | -- | -- | -$0.34 | -$0.34 | $0.01 |
| 05/10/2024 | Q1 | -- | -- | -$0.33 | -$0.41 | $0.08 |
| 02/22/2024 | Q4 | -- | -- | -$0.47 | -$0.43 | -$0.04 |
| 11/09/2023 | Q3 | -- | -- | -$0.41 | -$0.40 | -$0.01 |
| 08/10/2023 | Q2 | -- | -- | -$0.34 | -$0.40 | $0.06 |
| 05/11/2023 | Q1 | -- | -- | -$0.36 | -$0.35 | -$0.01 |
| 02/23/2023 | Q4 | -- | -- | -$0.30 | -$0.33 | $0.03 |
| 11/03/2022 | Q3 | -- | -- | -$0.34 | -$0.36 | $0.02 |
| 08/04/2022 | Q2 | -- | -- | -$0.32 | -$0.33 | $0.01 |
| 05/11/2022 | Q1 | -- | -- | -$0.30 | -$0.28 | -$0.02 |
| 02/24/2022 | Q4 | -- | -- | -$0.24 | -$0.26 | $0.02 |
| 11/10/2021 | Q3 | -- | -- | -$0.26 | -$0.24 | -$0.02 |
| 08/09/2021 | Q2 | -- | -- | -$0.21 | -$0.17 | -$0.04 |
| 05/13/2021 | Q1 | -- | -- | -$4.37 | -$0.15 | -$4.22 |
| 12/31/2020 | Q4 | -- | -- | -$0.14 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.16 | -- | -- |
Edgewise Therapeutics Earnings Questions
-
How Much did Edgewise Therapeutics Generate in Revenue Last Quarter?
Edgewise Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Edgewise Therapeutics Beat Earnings Last Quarter?
Edgewise Therapeutics announced earnings per share of -$0.42 which represents a beat of analyst forecast a -$0.42 per share.
-
Is Edgewise Therapeutics Profitable?
Edgewise Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Edgewise Therapeutics EPS Next Year?
Edgewise Therapeutics's earnings are forecast to decrease from -$1.45 per share to -$1.85 per share next year representing a decrease of -31.61%.
-
When is Edgewise Therapeutics's Earnings Date?
Edgewise Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
